|
COPB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.391200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.232560E-01 |
| Normal-vs-Stage2 |
8.787600E-01 |
| Normal-vs-Stage3 |
2.205800E-01 |
| Normal-vs-Stage4 |
9.840000E-01 |
| Stage1-vs-Stage2 |
5.605000E-01 |
| Stage1-vs-Stage3 |
3.042100E-02 |
| Stage1-vs-Stage4 |
7.442200E-01 |
| Stage2-vs-Stage3 |
2.992200E-01 |
| Stage2-vs-Stage4 |
9.415800E-01 |
| Stage3-vs-Stage4 |
5.571400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.426200E-01 |
| Normal-vs-AfricanAmerican |
5.264400E-01 |
| Normal-vs-Asian |
6.460400E-01 |
| Caucasian-vs-AfricanAmerican |
6.218600E-01 |
| Caucasian-vs-Asian |
6.212000E-01 |
| AfricanAmerican-vs-Asian |
4.402600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.925700E-02 |
| Normal-vs-Female |
2.677700E-03 |
| Male-vs-Female |
7.69059999999877E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.265400E-01 |
| Normal-vs-Extreme_Weight |
1.953910E-02 |
| Normal-vs-Obese |
7.469000E-01 |
| Normal-vs-Extreme_Obese |
5.090600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.357200E-01 |
| Normal_Weight-vs-Obese |
7.674000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.912800E-01 |
| Extreme_Weight-vs-Obese |
4.663600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.357400E-01 |
| Obese-vs-Extreme_Obese |
4.099600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.700620E-01 |
| Normal-vs-Age(41-60Yrs) |
3.808000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.951420E-01 |
| Normal-vs-Age(81-100Yrs) |
1.450970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.852560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.650200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.530200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.287900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.269800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.140000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.119000E-01 |
| Normal-VS-Type2 PRCC |
5.061200E-01 |
| Normal-VS-KIRP CIMP |
6.196000E-02 |
| Normal-VS-Unclassified PRCC |
3.786200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.129200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.036000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.504600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.099600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.244200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.096830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.538200E-02 |
| Normal-vs-N1 |
6.439600E-02 |
| Normal-vs-N2 |
7.315800E-01 |
| N0-vs-N1 |
1.159760E-02 |
| N0-vs-N2 |
6.242200E-01 |
| N1-vs-N2 |
9.942400E-01 |
|
|
